BELLINI: Venetoclax or placebo with bortezomib and dexamethasone for relapsed/refractory multiple myeloma
BELLINI: Venetoclax or placebo with bortezomib and dexamethasone for relapsed/refractory multiple myeloma
Transitioning from bortezomib to ixazomib in patients with multiple myeloma
Public policy in the fight against non-communicable diseases
Evaluating treatment options for acute myeloid leukaemia
Oncology Care Model: Improving value-based care
Lung cancer screening and the management of the pulmonary nodule
Cancer control in Africa - Special Issue
Immunotherapy for lung cancer before surgery
An overview of the latest advances in gastric cancer
Supportive care in cancer treatment
Using ctDNA to predict recurrence and response in colorectal cancer
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer